(19)
(11) EP 3 221 358 A1

(12)

(43) Date of publication:
27.09.2017 Bulletin 2017/39

(21) Application number: 15801630.3

(22) Date of filing: 17.11.2015
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
A61P 35/00(2006.01)
A61K 39/395(2006.01)
(86) International application number:
PCT/US2015/061014
(87) International publication number:
WO 2016/081423 (26.05.2016 Gazette 2016/21)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 18.11.2014 US 201462081134 P

(71) Applicant: Janssen Pharmaceutica, N.V.
2340 Beerse (BE)

(72) Inventors:
  • DONG, Jianying
    San Diego, CA 92121 (US)
  • CARDOSO, Rosa
    Spring House, PA 19477 (US)
  • ZHOU, Hong, Mimi
    San Diego, CA 92121 (US)
  • PIETSCH, Christine
    Spring House, PA 19477 (US)

(74) Representative: Cornish, Kristina Victoria Joy et al
Kilburn & Strode LLP 20 Red Lion Street
London WC1R 4PJ
London WC1R 4PJ (GB)

   


(54) CD47 ANTIBODIES, METHODS, AND USES